XOMA Royalty

Pharmaceuticals
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

$331.7M

Market Cap • 1/12/2026

1981

(45 years)

Founded

1986

(40 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country